130 related articles for article (PubMed ID: 3827951)
1. Inhibition of adenylosuccinate lyase by L-alanosyl-5-aminoimidazole-4-carboxylic acid ribonucleotide (alanosyl-AICOR).
Casey PJ; Lowenstein JM
Biochem Pharmacol; 1987 Mar; 36(5):705-9. PubMed ID: 3827951
[TBL] [Abstract][Full Text] [Related]
2. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase.
Tyagi AK; Cooney DA
Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of threo-beta-fluoroaspartate by H4 cells. Inhibition of adenylosuccinate lyase by fluoro analogs of its substrates.
Casey PJ; Abeles RH; Lowenstein JM
J Biol Chem; 1986 Oct; 261(29):13637-42. PubMed ID: 3759987
[TBL] [Abstract][Full Text] [Related]
4. Purification of adenylosuccinate lyase from rat skeletal muscle by a novel affinity column. Stabilization of the enzyme, and effects of anions and fluoro analogues of the substrate.
Casey PJ; Lowenstein JM
Biochem J; 1987 Sep; 246(2):263-9. PubMed ID: 3689310
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the toxicity of L-alanosine to various organs of the mouse.
Tyagi AK; Thake DC; McGee E; Cooney DA
Toxicology; 1981; 21(1):59-69. PubMed ID: 7281196
[TBL] [Abstract][Full Text] [Related]
6. The interaction of monofluorofumarate with adenylosuccinate lyase.
Kim SC; Raushel FM
J Enzyme Inhib; 1988; 2(3):153-61. PubMed ID: 3241180
[TBL] [Abstract][Full Text] [Related]
7. Purines, pyrimidines, and imidazoles. Part 50. Inhibition of adenylosuccinate AMP-lyase No. 4.3.2.2. by derivatives of N-(5-amino-1-beta-D-ribofuranosylimidazole-4-carbonyl)-L-aspartic acid 5'-phosphate (SAICAR) and virazole 5'-phosphate.
Shaw G; Thomas PS; Patey CA; Thomas SE
J Chem Soc Perkin 1; 1979; 6():1415-24. PubMed ID: 573277
[No Abstract] [Full Text] [Related]
8. Adenylosuccinate synthetase and adenylosuccinate lyase from Trypanosoma cruzi, Specificity studies with potential chemotherapeutic agents.
Spector T; Berens RL; Marr JJ
Biochem Pharmacol; 1982 Jan; 31(2):225-9. PubMed ID: 7037007
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the substrate specificity, kinetic and catalytic mechanism of adenylosuccinate lyase from Plasmodium falciparum.
Bulusu V; Srinivasan B; Bopanna MP; Balaram H
Biochim Biophys Acta; 2009 Apr; 1794(4):642-54. PubMed ID: 19111634
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.
Swain JL; Hines JJ; Sabina RL; Harbury OL; Holmes EW
J Clin Invest; 1984 Oct; 74(4):1422-7. PubMed ID: 6480832
[TBL] [Abstract][Full Text] [Related]
11. Nitro analogs of substrates for adenylosuccinate synthetase and adenylosuccinate lyase.
Porter DJ; Rudie NG; Bright HJ
Arch Biochem Biophys; 1983 Aug; 225(1):157-63. PubMed ID: 6351751
[TBL] [Abstract][Full Text] [Related]
12. The cleavage of adenylosuccinate and 5-amino-4-imidazole-N-succino-carboxamide ribonucleotide by an adenylosuccinate lyase from Ehrlich ascites tumor cells.
Brox LW
Can J Biochem; 1973 Jul; 51(7):1072-6. PubMed ID: 4737634
[No Abstract] [Full Text] [Related]
13. Characterization of a mutant Bacillus subtilis adenylosuccinate lyase equivalent to a mutant enzyme found in human adenylosuccinate lyase deficiency: asparagine 276 plays an important structural role.
Palenchar JB; Colman RF
Biochemistry; 2003 Feb; 42(7):1831-41. PubMed ID: 12590570
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification, and kinetic characterization of recombinant human adenylosuccinate lyase.
Stone RL; Zalkin H; Dixon JE
J Biol Chem; 1993 Sep; 268(26):19710-6. PubMed ID: 8366112
[TBL] [Abstract][Full Text] [Related]
15. Preparation of 5-amino-4-imidazole-N-succinocarboxamide ribotide, 5-amino-4-imidazole-N-succinocarboxamide riboside and succinyladenosine, compounds usable in diagnosis and research of adenylosuccinate lyase deficiency.
Zikánová M; Krijt J; Hartmannová H; Kmoch S
J Inherit Metab Dis; 2005; 28(4):493-9. PubMed ID: 15902552
[TBL] [Abstract][Full Text] [Related]
16. Detection of 5'-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity.
Laikind PK; Seegmiller JE; Gruber HE
Anal Biochem; 1986 Jul; 156(1):81-90. PubMed ID: 3740420
[TBL] [Abstract][Full Text] [Related]
17. The characterization of mutant Bacillus subtilis adenylosuccinate lyases corresponding to severe human adenylosuccinate lyase deficiencies.
Palenchar JB; Crocco JM; Colman RF
Protein Sci; 2003 Aug; 12(8):1694-705. PubMed ID: 12876319
[TBL] [Abstract][Full Text] [Related]
18. The structure of phosphate-bound Escherichia coli adenylosuccinate lyase identifies His171 as a catalytic acid.
Kozlov G; Nguyen L; Pearsall J; Gehring K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Sep; 65(Pt 9):857-61. PubMed ID: 19724117
[TBL] [Abstract][Full Text] [Related]
19. Inherent properties of adenylosuccinate lyase could explain S-Ado/SAICAr ratio due to homozygous R426H and R303C mutations.
Ray SP; Duval N; Wilkinson TG; Shaheen SE; Ghosh K; Patterson D
Biochim Biophys Acta; 2013 Aug; 1834(8):1545-53. PubMed ID: 23714113
[TBL] [Abstract][Full Text] [Related]
20. Screening for adenylosuccinate lyase deficiency using tandem mass spectrometry analysis of succinylpurines in neonatal dried blood spots.
Zikanova M; Krijt J; Skopova V; Krijt M; Baresova V; Kmoch S
Clin Biochem; 2015 Jan; 48(1-2):2-7. PubMed ID: 25445730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
